Structural characterization of a Type B chloramphenicol acetyltransferase from the emerging pathogen Elizabethkingia anophelis NUHP1.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
04 05 2021
Historique:
received: 10 12 2020
accepted: 24 03 2021
entrez: 5 5 2021
pubmed: 6 5 2021
medline: 2 2 2023
Statut: epublish

Résumé

Elizabethkingia anophelis is an emerging multidrug resistant pathogen that has caused several global outbreaks. E. anophelis belongs to the large family of Flavobacteriaceae, which contains many bacteria that are plant, bird, fish, and human pathogens. Several antibiotic resistance genes are found within the E. anophelis genome, including a chloramphenicol acetyltransferase (CAT). CATs play important roles in antibiotic resistance and can be transferred in genetic mobile elements. They catalyse the acetylation of the antibiotic chloramphenicol, thereby reducing its effectiveness as a viable drug for therapy. Here, we determined the high-resolution crystal structure of a CAT protein from the E. anophelis NUHP1 strain that caused a Singaporean outbreak. Its structure does not resemble that of the classical Type A CATs but rather exhibits significant similarity to other previously characterized Type B (CatB) proteins from Pseudomonas aeruginosa, Vibrio cholerae and Vibrio vulnificus, which adopt a hexapeptide repeat fold. Moreover, the CAT protein from E. anophelis displayed high sequence similarity to other clinically validated chloramphenicol resistance genes, indicating it may also play a role in resistance to this antibiotic. Our work expands the very limited structural and functional coverage of proteins from Flavobacteriaceae pathogens which are becoming increasingly more problematic.

Identifiants

pubmed: 33947893
doi: 10.1038/s41598-021-88672-z
pii: 10.1038/s41598-021-88672-z
pmc: PMC8096840
doi:

Substances chimiques

Anti-Bacterial Agents 0
Chloramphenicol O-Acetyltransferase EC 2.3.1.28

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

9453

Subventions

Organisme : NIGMS NIH HHS
ID : T34 GM008574
Pays : United States
Organisme : NIAID NIH HHS
ID : HHSN272201700059C
Pays : United States

Références

McBride, M. J. The family flavobacteriaceae. In The Prokaryotes (eds Rosenberg, E. et al.) 643–676 (Springer, Berlin, 2014).
Bernardet, J.-F. & Bowman, J. P. The genus flavobacterium. In The prokaryotes Vol. 7 (eds Dworkin, M. et al.) 481–531 (Springer, Berlin, 2006).
doi: 10.1007/0-387-30747-8_17
Loch, T. P. & Faisal, M. Emerging flavobacterial infections in fish: a review. J. Adv. Res. 6(3), 283–300 (2015).
pubmed: 26257926 doi: 10.1016/j.jare.2014.10.009
Avendaño-Herrera, R., Toranzo, A. E. & Magariños, B. Tenacibaculosis infection in marine fish caused by Tenacibaculum maritimum: A review. Dis. Aquat. Org. 71(3), 255–266 (2006).
doi: 10.3354/dao071255
Huang, L. et al. Type B chloramphenicol acetyltransferases are responsible for chloramphenicol resistance in Riemerella anatipestifer, China. Front. Microbiol. 8, 297 (2017).
pubmed: 28298905 pmcid: 5331189 doi: 10.3389/fmicb.2017.00297
Van Empel, P. & Hafez, H. Ornithobacterium rhinotracheale: A review. Avian Pathol. 28(3), 217–227 (1999).
pubmed: 26915377 doi: 10.1080/03079459994704
Vancanneyt, M. et al. Flavobacterium meningosepticum, a pathogen in birds. J. Clin. Microbiol. 32(10), 2398–2403 (1994).
pubmed: 7814473 pmcid: 264073 doi: 10.1128/jcm.32.10.2398-2403.1994
Vandamme, P. et al. Coenonia anatina gen. nov., sp. nov., a novel bacterium associated with respiratory disease in ducks and geese. Int. J. Syst. Evolut. Microbiol. 49(2), 867–874 (1999).
doi: 10.1099/00207713-49-2-867
Butler, T. Capnocytophaga canimorsus: an emerging cause of sepsis, meningitis, and post-splenectomy infection after dog bites. Eur. J. Clin. Microbiol. Infect. Dis. 34(7), 1271–1280 (2015).
pubmed: 25828064 doi: 10.1007/s10096-015-2360-7
Janda, J. M. & Lopez, D. L. Mini review: New pathogen profiles: Elizabethkingia anophelis. Diagn. Microbiol. Infect. Dis. 88(2), 201–205 (2017).
pubmed: 28342565 doi: 10.1016/j.diagmicrobio.2017.03.007
Perrin, A. et al. Evolutionary dynamics and genomic features of the Elizabethkingia anophelis 2015 to 2016 Wisconsin outbreak strain. Nat. Commun. 8, 15483 (2017).
pubmed: 28537263 pmcid: 5458099 doi: 10.1038/ncomms15483
King, E. O. Studies on a group of previously unclassified bacteria associated with meningitis in infants. Am. J. Clin. Pathol. 31(3), 241–247 (1959).
pubmed: 13637033 doi: 10.1093/ajcp/31.3.241
Ceyhan, M. & Celik, M. Elizabethkingia meningosepticum (Chryseobacterium meningosepticum) infections in children. Int. J. Pediatr. 2011, 215237 (2011).
pubmed: 22046191 pmcid: 3199185 doi: 10.1155/2011/215237
Nicholson, A. C. et al. Revisiting the taxonomy of the genus Elizabethkingia using whole-genome sequencing, optical mapping, and MALDI-TOF, along with proposal of three novel Elizabethkingia species: Elizabethkingia bruuniana sp. nov., Elizabethkingia ursingii sp. nov., and Elizabethkingia occulta sp. nov.. Antonie Van Leeuwenhoek 111(1), 55–72 (2018).
pubmed: 28856455 doi: 10.1007/s10482-017-0926-3
Li, Y. et al. Chryseobacterium miricola sp. nov., a novel species isolated from condensation water of space station Mir. Syst. Appl. Microbiol. 26(4), 523–528 (2003).
pubmed: 14666980 doi: 10.1078/072320203770865828
Zdziarski, P., Paściak, M., Rogala, K., Korzeniowska-Kowal, A. & Gamian, A. Elizabethkingia miricola as an opportunistic oral pathogen associated with superinfectious complications in humoral immunodeficiency: A case report. BMC Infect. Dis. 17(1), 1–6 (2017).
doi: 10.1186/s12879-017-2886-7
Hsu, M.-S. et al. Clinical features, antimicrobial susceptibilities, and outcomes of Elizabethkingia meningoseptica (Chryseobacterium meningosepticum) bacteremia at a medical center in Taiwan, 1999–2006. Eur. J. Clin. Microbiol. Infect. Dis. 30(10), 1271–1278 (2011).
pubmed: 21461847 doi: 10.1007/s10096-011-1223-0
Bloch, K. C., Nadarajah, R. & Jacobs, R. Chryseobacterium meningosepticum: an emerging pathogen among immunocompromised adults. Report of 6 cases and literature review. Medicine 76(1), 30–41 (1997).
pubmed: 9064486 doi: 10.1097/00005792-199701000-00003
Chen, S., Bagdasarian, M. & Walker, E. D. Elizabethkingia anophelis: molecular manipulation and interactions with mosquito hosts. Appl. Environ. Microbiol. 81(6), 2233–2243 (2015).
pubmed: 25595771 pmcid: 4345385 doi: 10.1128/AEM.03733-14
Lau, S. K. et al. Evidence for Elizabethkingia anophelis transmission from mother to infant, Hong Kong. Emerg. Infect. Dis. 21(2), 232 (2015).
pubmed: 25625669 pmcid: 4313635 doi: 10.3201/eid2102.140623
Garay, J. A. R., Hughes, G. L., Koundal, V., Rasgon, J. L. & Mwangi, M. M. Genome sequence of Elizabethkingia anophelis strain EaAs1, isolated from the Asian malaria mosquito Anopheles stephensi. Genome Announc. 4(2), e00084-e116 (2016).
Doijad, S., Ghosh, H., Glaeser, S., Kämpfer, P. & Chakraborty, T. Taxonomic reassessment of the genus Elizabethkingia using whole-genome sequencing: Elizabethkingia endophytica Kämpfer et al. 2015 is a later subjective synonym of Elizabethkingia anophelis Kämpfer et al. 2011. Int. J. Syst. Evol. Microbiol. 66(11), 4555–4559 (2016).
pubmed: 27498788 doi: 10.1099/ijsem.0.001390
Xu, J., Pei, D., Nicholson, A., Lan, Y. & Xia, Q. In silico identification of three types of integrative and conjugative elements in Elizabethkingia anophelis strains isolated from around the world. Msphere. 4(2), e00040-19 (2019).
pubmed: 30944210 pmcid: 6449604 doi: 10.1128/mSphere.00040-19
Zhu, D. et al. First report of integrative conjugative elements in Riemerella anatipestifer isolates from ducks in china. Front. Vet. Sci. 6, 128 (2019).
pubmed: 31069241 pmcid: 6491836 doi: 10.3389/fvets.2019.00128
Li, Y. et al. Complete genome sequence and transcriptomic analysis of the novel pathogen Elizabethkingia anophelis in response to oxidative stress. Genome Biol. Evol. 7(6), 1676–1685 (2015).
pubmed: 26019164 pmcid: 4494045 doi: 10.1093/gbe/evv101
Breurec, S. et al. Genomic epidemiology and global diversity of the emerging bacterial pathogen Elizabethkingia anophelis. Sci. Rep. 6, 30379 (2016).
pubmed: 27461509 pmcid: 4961963 doi: 10.1038/srep30379
Alcala, A. et al. Structural and functional characterization of three Type B and C chloramphenicol acetyltransferases from Vibrio species. Protein Sci. 29(3), 695–710 (2020).
pubmed: 31762145 doi: 10.1002/pro.3793
Biswas, T., Houghton, J. L., Garneau-Tsodikova, S. & Tsodikov, O. V. The structural basis for substrate versatility of chloramphenicol acetyltransferase CATI. Protein Sci. 21(4), 520–530 (2012).
pubmed: 22294317 pmcid: 3375752 doi: 10.1002/pro.2036
Beaman, T. W., Sugantino, M. & Roderick, S. L. Structure of the hexapeptide xenobiotic acetyltransferase from Pseudomonas aeruginosa. Biochemistry 37(19), 6689–6696 (1998).
pubmed: 9578552 doi: 10.1021/bi980106v
Bryan, C. M. et al. High-throughput protein production and purification at the Seattle Structural Genomics Center for Infectious Disease. Acta Crystallogr. Sect. F: Struct. Biol. Cryst. Commun. 67(9), 1010–1014 (2011).
doi: 10.1107/S1744309111018367
Kabsch, W. Integration, scaling, space-group assignment and post-refinement. Acta Crystallogr. D Biol. Crystallogr. 66(2), 133–144 (2010).
pubmed: 20124693 pmcid: 2815666 doi: 10.1107/S0907444909047374
Vagin, A., Lebedev, A. (ed.) MoRDa, an automatic molecular replacement pipeline. Acta Crystallographica A-Foundation and Advances (Int Union Crystallography 2 Abbey Sq, Chester, Ch1 2hu, England, 2015).
Emsley, P. & Cowtan, K. Coot: Model-building tools for molecular graphics. Acta Crystallogr. D Biol. Crystallogr. 60(12), 2126–2132 (2004).
pubmed: 15572765 doi: 10.1107/S0907444904019158
Adams, P. D. et al. PHENIX: A comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. D Biol. Crystallogr. 66(2), 213–221 (2010).
pubmed: 20124702 pmcid: 2815670 doi: 10.1107/S0907444909052925
Chen, V. B. et al. MolProbity: All-atom structure validation for macromolecular crystallography. Acta Crystallogr. D Biol. Crystallogr. 66(1), 12–21 (2010).
doi: 10.1107/S0907444909042073 pubmed: 20057044
McArthur, A. G. et al. The comprehensive antibiotic resistance database. Antimicrob. Agents Chemother. 57(7), 3348–3357 (2013).
pubmed: 23650175 pmcid: 3697360 doi: 10.1128/AAC.00419-13
Seong, H. et al. Risk Factors for mortality in patients with Elizabethkingia infection and the clinical impact of the antimicrobial susceptibility patterns of Elizabethkingia species. J. Clin. Med. 9(5), 1431 (2020).
pmcid: 7290601 doi: 10.3390/jcm9051431
Ren, X. et al. Riemerella anatipestifer AS87_RS09170 gene is responsible for biotin synthesis, bacterial morphology and virulence. Sci. Rep. 8(1), 1–13 (2018).
doi: 10.1038/s41598-018-32905-1
Ryll, M. et al. Studies on the prevalence of Riemerella anatipestifer in the upper respiratory tract of clinically healthy ducklings and characterization of untypable strains. J. Vet. Med. Ser. B 48(7), 537–546 (2001).
doi: 10.1046/j.1439-0450.2001.00471.x
Kukutla, P. et al. Insights from the genome annotation of Elizabethkingia anophelis from the malaria vector Anopheles gambiae. PLoS ONE 9(5), e97715 (2014).
pubmed: 24842809 pmcid: 4026382 doi: 10.1371/journal.pone.0097715
Chen, S. et al. Comparative genomic analyses reveal diverse virulence factors and antimicrobial resistance mechanisms in clinical Elizabethkingia meningoseptica strains. PLoS ONE 14(10), e0222648 (2019).
pubmed: 31600234 pmcid: 6786605 doi: 10.1371/journal.pone.0222648
Singh, R., Sahore, S., Kaur, P., Rani, A. & Ray, P. Penetration barrier contributes to bacterial biofilm-associated resistance against only select antibiotics, and exhibits genus-, strain-and antibiotic-specific differences. Pathog. Dis. 74(6), ftw056 (2016).
pubmed: 27402781 doi: 10.1093/femspd/ftw056
Drago, L. Chloramphenicol resurrected: A journey from antibiotic resistance in eye infections to biofilm and ocular microbiota. Microorganisms. 7(9), 278 (2019).
pmcid: 6780676 doi: 10.3390/microorganisms7090278
Dinos, G. P. et al. Chloramphenicol derivatives as antibacterial and anticancer agents: historic problems and current solutions. Antibiotics. 5(2), 20 (2016).
pmcid: 4929435 doi: 10.3390/antibiotics5020020
Nagabhushan, T., Miller, G. H., Varma, K. J. Chloramphenicol and analogues. Kirk‐Othmer Encyclopedia of Chemical Technology (2000).
Lo Leggio, L., Dal Degan, F., Poulsen, P., Andersen, S. M. & Larsen, S. The structure and specificity of Escherichia coli maltose acetyltransferase give new insight into the LacA family of acyltransferases. Biochemistry 42(18), 5225–5235 (2003).
pubmed: 12731863 doi: 10.1021/bi0271446
Pauly, M. & Ramírez, V. New insights into wall polysaccharide O-acetylation. Front. Plant Sci. 9, 1210 (2018).
pubmed: 30186297 pmcid: 6110886 doi: 10.3389/fpls.2018.01210
Wang, M. et al. The antibiotic resistance and pathogenicity of a multidrug-resistant Elizabethkingia anophelis isolate. MicrobiologyOpen. 8(11), e804 (2019).
pubmed: 30891912 pmcid: 6854844 doi: 10.1002/mbo3.804

Auteurs

Seyed Mohammad Ghafoori (SM)

School of Biomedical Sciences, Charles Sturt University, Wagga Wagga, NSW, 2650, Australia.

Alyssa M Robles (AM)

Department of Chemistry and Biochemistry, San Francisco State University, San Francisco, CA, USA.

Angelika M Arada (AM)

Department of Chemistry and Biochemistry, San Francisco State University, San Francisco, CA, USA.

Paniz Shirmast (P)

School of Biomedical Sciences, Charles Sturt University, Wagga Wagga, NSW, 2650, Australia.

David M Dranow (DM)

Seattle Structural Genomics Center for Infectious Disease, Seattle, WA, USA.
UCB Pharma, Bainbridge Island, WA, USA.

Stephen J Mayclin (SJ)

Seattle Structural Genomics Center for Infectious Disease, Seattle, WA, USA.
UCB Pharma, Bainbridge Island, WA, USA.

Donald D Lorimer (DD)

Seattle Structural Genomics Center for Infectious Disease, Seattle, WA, USA.
UCB Pharma, Bainbridge Island, WA, USA.

Peter J Myler (PJ)

Seattle Structural Genomics Center for Infectious Disease, Seattle, WA, USA.
Seattle Children's Research Institute, University of Washington, Seattle, WA, USA.

Thomas E Edwards (TE)

Seattle Structural Genomics Center for Infectious Disease, Seattle, WA, USA.
UCB Pharma, Bainbridge Island, WA, USA.

Misty L Kuhn (ML)

Department of Chemistry and Biochemistry, San Francisco State University, San Francisco, CA, USA.

Jade K Forwood (JK)

School of Biomedical Sciences, Charles Sturt University, Wagga Wagga, NSW, 2650, Australia. jforwood@csu.edu.au.

Articles similaires

Vancomycin-associated DRESS demonstrates delay in AST abnormalities.

Ahmed Hussein, Kateri L Schoettinger, Jourdan Hydol-Smith et al.
1.00
Humans Drug Hypersensitivity Syndrome Vancomycin Female Male
Humans Arthroplasty, Replacement, Elbow Prosthesis-Related Infections Debridement Anti-Bacterial Agents
Coal Metagenome Phylogeny Bacteria Genome, Bacterial
Vancomycin Polyesters Anti-Bacterial Agents Models, Theoretical Drug Liberation

Classifications MeSH